Eisai Co. Ltd.'s Fiscal Year is From April To March - All Figures are in Days.
The item "Cash-Conversion-Cycle" stands at 431.60 days as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.
As of the end of Eisai Co. Ltd.'s second quarter, the item "Cash Conversion Cycle" stands at 431.60 Days. This represents an increase of 4.05 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 5.25 percent compared to the value the year prior.
The 1 year change in percent is 5.25.
The 3 year change in percent is 216.98.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Cash Conversion Cycle | 905,699,262,464.00 |
![]() | Johnson & Johnson - Cash Conversion Cycle | 486,508,953,600.00 |
![]() | AbbVie Inc - Cash Conversion Cycle | 399,570,305,024.00 |
![]() | Roche Holding AG - Cash Conversion Cycle | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Cash Conversion Cycle | 280,205,508,085.11 |